Summary
Published in Biotechnology Journal (2020), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Mó, Inês, et al. Assessing the Combinatorial Chemo‐Photothermal Therapy Mediated by Sulfobetaine Methacrylate‐Functionalized Nanoparticles in 2D and 3D In Vitro Cancer Models
Assessing the Combinatorial Chemo‐Photothermal Therapy Mediated by Sulfobetaine Methacrylate‐Functionalized Nanoparticles in 2D and 3D In Vitro Cancer Models
Research Overview
Nanoparticle-mediated combination therapies are usually screened in 2D culture — and this study shows why that can mislead. Doxorubicin- and IR780-loaded, sulfobetaine-methacrylate-functionalized nanoparticles were tested in parallel on cancer cell monolayers and on 3D spheroids. In 2D, photothermal, chemo, and combined chemo-photothermal treatment cut viability to about 58%, 29%, and 1% respectively.
On 3D spheroids, however, the photothermal arm alone produced no cytotoxic effect — a striking 2D-versus-3D divergence that argues for spheroid-based screening in nanomedicine development, where the tumor-like architecture of the model changes the measured outcome.
Key Discoveries
- Chemo-photothermal combination nearly eliminated cancer cells in 2D (1% viability remaining)
- The same photothermal treatment showed no cytotoxicity when tested on 3D spheroids
- Direct evidence that 2D screening can overstate nanomedicine efficacy versus 3D tumor models
